https://www.selleckchem.com/pr....oducts/lenalidomide-
5%, 27.5%, and 35.5% in the 0h, 0-1h, 1-2h, and 2h treatment groups, respectively. Patients with respiratory failure due to pulmonary disease using NRM over 2h had a higher mortality rate than patients not using NRM (hazard ratio 1.3, 95% CI 1.01-1.66). Prolonged use of NRM in patients with respiratory failure due to pulmonary disease possibly increases mortality. Prolonged use of NRM in patients with respiratory failure due to pulmonary disease possibly increases mortality. Rectal injury is a rare complication after extr
Like
Comment
Share
